technology Archives

BNMC & Partners Awarded up to $8.2 Million to Improve Transportation Access.

February 18, 2021 by Maria Morrealein Collaboration, Commuting, Innovation, News

The United States Department of Transportation (USDOT) has selected the Buffalo Niagara Medical Campus (BMNC) as one of five U.S. locations to pilot the Complete Trip – ITS4US Deployment Program. The Complete Trip – ITS4US Deployment Program challenges communities to identify ways to provide more efficient, affordable, and accessible transportation options for underserved populations that often face greater challenges in accessing essential services.

Continue reading “BNMC & Partners Awarded up to $8.2 Million to Improve Transportation Access.”

M&T’s New Tech Startup Makes Business First

March 5, 2020 by BNMCin Buffalo, Business Development, Innovation Center, Local businesses, News, Startups, Technology

Congratulations to M&T Bank on its feature in Buffalo Business First for the establishment of new tech company Nota! Nota – a digital banking solution — functions like any other fast-growing startup in the Thomas R. Beecher Jr. Innovation Center. The only difference? It was created by one of the region’s largest companies. To read more about M&T’s new tech company, CLICK HERE!
(Pictured: Paul Garibian, who leads M&T’s new tech startup, Nota.)

New Biotech Companies Move Into Innovation Center on the Buffalo Niagara Medical Campus

March 11, 2013 by BNMCin Biotechnology Companies, Healthy Communities, Homepage, Innovation Center, Member Institution(s), News

The Thomas R. Beecher, Jr. Innovation Center is pleased to welcome Roswell Park Cancer Institute (RPCI) spin-off companies Tartis Aging, Inc., and OncoTartis, Inc., as its newest tenants. The companies will occupy a combined 5,700-square-foot of wet lab and office space on the fourth floor of the building. Approximately half of this space will be built up as the companies continue to grow in size.
OncoTartis and Tartis Aging are discovery-stage biotechnology companies seeking novel anti-cancer and anti-aging drugs. Their proprietary technologies are licensed from the laboratories of Andrei Gudkov, PhD, from RPCI.

Dr. Gudkov was recruited to Buffalo by RPCI and other local partners in 2007. He moved his research lab and his first commercial company, Cleveland BioLabs, Inc. (CBLI), from the Cleveland Clinic to serve as Senior Vice President of Basic Science and Chair of the Department of Cell Stress Biology at Roswell Park.

The laboratory building at 73 High Street, shared with Cleveland BioLabs, Inc., had been the first home for both corporations. With 15 employees and a growing portfolio, the two companies have outgrown the space available on High Street but wanted to remain on the BNMC.

“We are very hwp-contenty to find space in the Innovation Center, which allows us to expand our research and at the same time continue to be close to our colleagues at CBLI and Roswell Park,” said Aleksandra Kotlyarova, Director of Operations for both companies.

“OncoTartis and Tartis Aging are perfect examples of what we need to see more of here in Buffalo,” said Patrick J. Whalen, Chief Operating Officer of the BNMC, Inc., which owns and operates the Innovation Center. “Dr. Gudkov and Cleveland BioLabs moved to the BNMC several years ago to better collaborate with Roswell Park Cancer Institute, and thanks to the groundbreaking research at Roswell Park, they continue to grow and spin off companies, creating more jobs and economic-development opportunities in Buffalo as they evolve.”

Kari Bonaro (BNMC, Inc.); kbonaro@bnmc-old.local; 716.218.7157

New Biotech Companies Move Into Innovation Center on the Buffalo Niagara Medical Campus

March 11, 2013 by BNMCin Campus-wide, Innovation Center, News, Research

FOR IMMEDIATE RELEASE
Monday, March 11, 2013

For more information, contact:

Contact Kari Bonaro
kbonaro@bnmc-old.local, 716.218.7157

(BUFFALO, NY) – The Thomas R. Beecher, Jr. Innovation Center is pleased to welcome Roswell Park Cancer Institute (RPCI) spin-off companies Tartis Aging, Inc., and OncoTartis, Inc., as its newest tenants. The companies will occupy a combined 5,700 sq. ft. of wet lab and office space on the fourth floor of the building. Approximately half of this space will be built up as the companies continue to grow in size.

OncoTartis and Tartis Aging are discovery-stage biotechnology companies seeking novel anti-cancer and anti-aging drugs. Their proprietary technologies are licensed from the laboratories of Andrei Gudkov, PhD, from RPCI.

About the Buffalo Niagara Medical Campus

The Buffalo Niagara Medical Campus (BNMC) is dedicated to the cultivation of a world-class medical campus for clinical care, research, education, and entrepreneurship on 120 acres in downtown Buffalo. It is home to the region’s top clinical, research, and medical education institutions, including: the University at Buffalo, Roswell Park Cancer Institute, Olmsted Center for Sight, Kaleida Health, Hauptman-Woodward Medical Research Institute, Buffalo Medical Group, Buffalo Hearing & Speech Center, Unyts, and the Center for Hospice and Palliative Care. There are over 40 public and private companies on the BNMC. More than 12,000 people come to work at the Medical Campus every day, and BNMC institutions see over one million patients and visitors annually. The Campus has an annual economic impact of $1.5 billion on the region. The Medical Campus consists of more than 6 million square feet of research, clinical, and support space. bnmc-old.local

About Roswell Park Cancer Institute

The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email askrpci@roswellpark.org.

About the Thomas R. Beecher Innovation Center

The Thomas R. Beecher, Jr. Innovation Center, located at 640 Ellicott Street in downtown Buffalo, is a LEED-certified research and development space housing life sciences and biotech companies, as well as companies offering support services like IP attorneys, talent acquisition, sales, and marketing. This state-of-the art facility is designed to accommodate small to medium companies seeking office, wet lab and/or research space, on a month-to-month basis or via longer term leases, located in the heart of the thriving Buffalo Niagara Medical Campus. There are currently 40 companies located in the building.

The Innovation Center is owned and operated by the BNMC, Inc., a not-for-profit organization that fosters conversation and collaboration among its member institutions, their 12,000 employees, and the community; coordinates activities related to sustainable planning, development and enhancement of its 120-acre space; and works to create a distinct, innovative environment that provides opportunities for entrepreneurship and active and healthy living.

###

International Partnership to Train and Educate Future Nanotechnologists in Zimbabwe

February 21, 2013 by BNMCin Homepage, Life Sciences Companies, Member Institution(s), Research5 Comments

The University at Buffalo (UB) welcomed Minister of Science and Technology Development of Zimbabwe, Professor Heneri Dzinotyiweyi to Buffalo to tour its Institute for Lasers, Photonics and Biophotonics (ILPB) and New York State Center of Excellence in Bioinformatics and Life Sciences (CoE). Both research facilities will play a role in the international academic partnership with the University of Zimbabwe and Chinhoyi University of Technology.
Receiving the award to establish a Fogarty International Center AIDS International Training and Research Program (AITRP) in 2009, UB professor, CoE associate director, and director of Translational Pharmacy Research Gene D. Morse, PharmD and collaborators set out to use the award for its intended purpose, providing education and training for HIV-related research in low- and middle-income countries.

Through the Zimbabwe International Nanotechnology Center (ZINC), the collaboration will primarily serve as a nanotechnology research program where UB will help educate and train young researchers at the University of Zimbabwe and the Chinhoyi University of Technology to wp-contently nanotechnology to treat and prevent prevalent diseases like HIV/AIDS, tuberculosis and malaria in the south-African country. Nanotechnology is molecular manufacturing on a 100 nanometer or smaller scale. Nano-particles (particles with dimensions less than 100 nanometers) have become important to the equation of new HIV/AIDS drug development because they can provide effective treatment options with shortened duration of therapy, reduced systemic side effects and limited development of drug resistance.

With 14 percent of Zimbabwe’s population living with HIV/AIDS and tuberculosis as a co-infection, the need for new drugs and new formulations of available treatments is crucial.

To prepare for ZINC implementation and discuss logistics, Morse and Paras Prasad, PhD, SUNY Distinguished Professor in the Departments of Chemistry, Physics, Medicine and Electrical Engineering and Samuel P. Capen Chair of Chemistry invited Professor Dzinotyiweyi to Western New York. “Professor Dzinotyiweyi’s visits to the ILPB, as well as the center, provided an opportunity for faculty leaders, regional scientists and public officials to discuss the recently announced international collaboration of UB and ZINC,” says Morse.

A public symposium will take place in Harare, Zimbabwe on March 18th and 19th. The symposium will include representatives from government, academia and the community. Meetings in Zimbabwe and Buffalo are scheduled to help all participants continue to get acquainted.

A future hope is to develop partnerships with pharmaceutical and biotechnology companies, drawing private-sector investments. In addition to that goal, a positive effect on economic development is expected to take place in Western New York and in Zimbabwe.

UB Medical School to Develop Tools for Cloud-Based Simulations of Patient Visits

January 25, 2013 by BNMCin Homepage, Member Institution(s), News4 Comments

UB is one of eight institutions in the U.S. chosen to write patient cases

The American Medical Association is providing funding to support the University at Buffalo (UB) School of Medicine and Biomedical Sciences and other institutions in a national consortium to develop simulated, interactive “encounters” with virtual patients to supplement the education of students in the third year of medical school.

The i-Human Patients platform is a cloud-based service for medical students that simulates a patient visit. Students use the software to interview and examine animations of patients, order and review diagnostic tests, develop diagnostic hypotheses and create a treatment plan. Online guidance and comprehensive feedback occurs at every step of the process.

Avery Ellis, MD, PhD, associate professor of medicine and physiology and senior associate dean for medical curriculum at UB, is one of 8 faculty members at prestigious institutions throughout the U.S., who will be working together to develop simulations for internal medicine. Ellis and Susan J. Gallagher, MD, clinical associate professor of medicine at UB and director for internal medicine clerkships in the third and fourth years, will be writing cases on chest pain, heart failure, chronic obstructive pulmonary disease, edema, electrolyte abnormalities, syncope, dizziness and hyperlipidemia.

The new cases are expected to be completed, peer-reviewed and included in the curriculum that third-year medical students at UB experience starting in July, Ellis says.

“These very sophisticated patient simulations will round out the education of third-year medical students,” says Ellis. “For our students, working on these patient simulations, complete with actual test results and realistic clinical data, such as audible heart sounds, angiograms and ultrasound studies, is far more beneficial than just reading about the same disease in a textbook.”

The cases are being prepared by faculty at UB and at the University of Chicago, Columbia University, Cornell University, Northwestern University, Tufts University, Rush University and Stony Brook University.

“These interactive web-based patient encounters will nicely complement the other kinds of experiences our students are getting at UB’s Behling Simulation Center,” Ellis adds.

“The American Medical Association is funding the development of medical school cases and other interactive content for the i-Human Patients educational services platform because we see a need to accelerate student training in patient assessment and diagnostic skills,” says James Madara, chief executive officer/education vice president for the AMA.

i-Human Patients Inc. is a designer and developer of “virtual” medical training products and services.

Ellen Goldbaum (UB); goldbaum@buffalo.edu; 716.645.4605

UB Recruiting Innovators in Life Sciences for High-Tech CEL

January 11, 2013 by BNMCin Campus-wide, Entrepreneurs, Homepage, Life Sciences Companies, News6 Comments

Program Offers Entrepreneurial Guidance, Knowledge and Mentorship for those in Field

Leaders of early-stage life sciences and technology companies can take advantage of a High-Tech Center for Entrepreneurial Leadership (CEL) program that will begin in March 2013.

Now in its third year, the High Tech CEL is a collaboration between the Center for Entrepreneurial Leadership (CEL) in the University at Buffalo School of Management and UB’s New York State Center of Excellence in Bioinformatics and Life Sciences.

With funding from a number of sources, including an Economic Development Administration grant and an award from UB’s “E Fund,” the program’s mission is to help participants build a strong management team and develop an individualized pathway toward commercialization.

Participants of the 10-week program meet for two hours a week, covering a range of topics, including commercialization strategies, finance issues, intellectual property, FDA regulations, investor relations, sales and marketing, and more.

“The High-Tech CEL is a unique opportunity for entrepreneurs to build their business skills, gain hands-on experience, and learn from other professionals who understand the challenges they’re facing,” said Thomas Ulbrich, executive director of UB’s Center for Entrepreneurial Leadership.

“This program is greatly beneficial for those whose firms are in the initial phase of taking their work from the lab to the market,” said Marnie LaVigne, PhD, associate vice president of economic development at UB. “It incorporates key high-tech business topics into the strength of the time-tested CEL program that has helped hundreds of traditional businesses in the region grow since 1987.”

Case studies, roundtables, panel discussions and lectures make up the curriculum, and each participant is partnered with a seasoned, successful entrepreneur who is attuned to the issues that influence business decisions. These mentors guide, advise and support participants throughout the program to help them achieve specific objectives.

The High-Tech CEL program is engaging and interactive and focuses on the importance of initiating and nurturing relationships between early-stage companies and leaders in the Buffalo-Niagara life science and technology ecosystem by providing structured networking opportunities throughout the duration of the program.

Charles d’Estries, director of SciBiz International Inc., will moderate the program. He provides business development consulting for entrepreneurs in the life sciences and high-tech fields, particularly those in the early stages of business.

Program cost is $995 per participant, and consecutive participants from the same company can attend at a 50 percent discount ($497).

To learn more or wp-contently, contact the CEL at 716-885-5715 or mgt-cel@buffalo.edu.

The mission of UB’s New York State Center of Excellence in Bioinformatics and Life Sciences (COE) is to study the mechanistic processes involved in human disease with the goal of developing diagnostics tools and therapeutic interventions, preventative treatment and other disease management devices and processes to improve the health and well-being of the population. This scientific mission is balanced by the COE’s responsibility to act as a facilitator of economic development in Upstate New York by building and supporting partnerships between academia, industry and government. More information is available at http://www.bioinformatics.buffalo.edu.

The UB School of Management is recognized for its emphasis on real-world learning, community and economic impact, and the global perspective of its faculty, students and alumni. The school has been ranked by Bloomberg Businessweek, the Financial Times, Forbes, U.S. News & World Report and The Wall Street Journal for the quality of its programs and the return on investment it provides its graduates. For more information about the UB School of Management, visit http://mgt.buffalo.edu.

Jacqueline Ghosen, UB School of Management; ghosen@buffalo.edu; 716-645-2833

UB Partners with Zimbabwe Universities to Create International Nanotechnology Center

September 24, 2012 by BNMCin Life Sciences Companies, Member Institution(s), News, ResearchLeave a Comment

For release: September 24, 2012Contact: Sara R. Saldi, saldi@buffalo.edu
University at Buffalo
716-645-4593

UB Partners with Zimbabwe Universities to Create International Nanotechnology Center

BUFFALO, N.Y. — With 14 percent of Zimbabwe’s population living with HIV/AIDS and tuberculosis as a co-infection, the need for new drugs and new formulations of available treatments is crucial.

To address these issues, two of the University at Buffalo’s leading research centers, the Institute for Lasers, Photonics and Biophotonics (ILPB), and the New York State Center of Excellence in Bioinformatics and Life Sciences have signed on to launch the Zimbabwe International Nanotechnology Center (ZINC) — a national nanotechnology research program — with the University of Zimbabwe (UZ) and the Chinhoyi University of Technology (CUT).

This collaborative program will initially focus on research in nanomedicine and biosensors at UZ and energy at CUT. ZINC has grown out of the NIH Fogarty International Center, AIDS International Training and Research Program (AITRP) that was awarded to UB and UZ in 2008 to conduct HIV research training and build research capacity in Zimbabwe and neighboring countries in southern Africa.

UB faculty and research directors in the ZINC partnership include Paras N. Prasad, PhD, SUNY Distinguished Professor of Chemistry, Physics, Medicine and Electrical Engineering, the Samuel P. Capen Chair, executive director of ILPB; Gene D. Morse, PharmD, Professor of Pharmacy Practice, associate director of the New York State Center of Excellence in Bioinformatics and Life Sciences and director of the Translational Pharmacy Research Core; Alexander N. Cartwright, PhD, UB vice president for research and economic development and interim executive director of the New York State Center of Excellence in Bioinformatics and Life Sciences , who will work with Professor Levi Nyagura, UZ vice chancellor; Professor David T. Simbi, CUT vice chancellor, and Dr. Charles Maponga, PharmD, UZ pharmacy school director.

ZINC will establish a long-term international research and training platform in the field of nanotechnology, focused in areas that promote Zimbabwe’s strength, and advance the development of nanotechnology as an avenue for Zimbabwe’s commercial growth.

The UB ILPB and TPRC collaboration recognized that the fields of pharmacology and therapeutics have increasingly developed links with emerging areas within the field of nanosciences in an attempt to develop tissue/organ targeted strategies that will lead to disease treatment and eradication. Research teams will focus on emerging technologies, initially focused in nanobiotechnology and nanomedicine for health care.

“Developing nanoformulations for HIV and tuberculosis diagnostics and therapeutics, as well as new tuberculosis drug development, are just a few of the innovative strategies to address these co-infections that this research collaboration can provide,” said Morse.

“In addition, the development of new nanotechnology-related products will jumpstart the economy and foster new economic initiatives in Zimbabwe that will yield additional private-public partnerships.”

A photo of Morse is available at: http://www.buffalo.edu/news/13694.

Morse says that the current plans for a “Center of Excellence” in clinical and translational pharmacology in Harare at UZ will create a central hub in Africa, not just for Zimbabwe but for other countries to gain new training and capacity building in many exciting aspects of nanotechnology as well.

Morse adds that this initiative creates an opportunity for additional involvement from a number of UB centers such as those represented by UB’s Strategic Strengths in areas such as Health and Wellness across the Lifespan, Integrated Nanostructured Systems, Molecular Recognition in Biological Systems and Bioinformatics and Information and Computing Technology.

“With an international program like ZINC, we are hoping to attract pharmaceutical companies and biotechnology firms who will have similar interests in joining this unique partnership that will enhance the likelihood of economic success through efficient, innovative research.”

“Locally, these efforts will be linked to the growing Buffalo Niagara Medical Campus resulting in a truly global partnership with one anchor in Buffalo–a comprehensive ‘UB matrix’ of innovation and excellence,” says Morse.

UB Awarded $1.6M Grant for Students to Study Cybersecurity

September 18, 2012 by BNMCin Member Institution(s), ResearchLeave a Comment

News Release

Cory Nealon

cmnealon@buffalo.edu

716-645-4614

Release Date: September 18, 2012

BUFFALO, N.Y. — The University at Buffalo has received a $1.6 million federal grant to teach students how to protect the United States from cyberattacks.

UB will use the grant, awarded by the National Science Foundation, to bring up to 16 students into its Center of Excellence in Information Systems, Assurance, Research and Education (CEISARE). It is one of wp-contentroximately 50 federally designated centers that supply the United States with graduates trained to protect the nation from computer-based attacks. For more information, visit: http://www.cse.buffalo.edu/caeiae.

The grant will cover the cost of student stipends ($25,000), in-state graduate tuition and fees ($12,000) and books, travel expenses and health insurance ($3,000) for two years. At roughly $80,000 per student, this equals $1.3 million. The remainder of the grant, roughly $345,000, will cover the cost of running the center for five years.

In exchange for the financial support, students must agree to work for the federal government for two years upon graduation. CEISARE Director Shambhu Upadhyaya said students can choose from numerous agencies including the National Security Agency, the Department of Homeland Security, the Department of Defense and the FBI.

“When students graduate with a specialty in cybersecurity, they can basically go wherever they want,” said Upadhyaya, professor of computer science and engineering.

For a picture of Upadhyaya, visit: http://ubphoto.smugmug.com.

An interdisciplinary program, CEISARE includes a varied group of UB faculty. For example, the grant’s co-investigators are: Thomas Cusick, professor of mathematics; H. Raghav Rao, SUNY Distinguished Service Professor in management science and systems department; and Mark Bartholomew, associate professor of law.

The diversity reflects the nuances of computer warfare, which Homeland Security Secretary Janet Napolitano has said is the most serious economic and national security threat that the United States faces. She and other national security officials have warned that electric grids, transportation systems, banks and other industries reliant on computer systems are susceptible to cyberattacks.

Upadhyaya pointed to the 2009 hacking of sensitive information from the Pentagon’s $300 billion, F-35 Joint Strike Fighter project as an example.

The $1.6 million grant is the second multi-year award received by CEISARE. In 2008, it received $860,000 to educate 11 students, some of whom went on to work for the National Security Agency, the Federal Trade Commission and the Office of Inspector General.

WTCBN Receives Funds to Help Increase Medical Device Trade Between WNY Manufacturers and China

September 6, 2012 by BNMCin Entrepreneurs, Investment Opportunities, NewsLeave a Comment

The World Trade Center of Buffalo Niagara (WTCBN), a local not-for-profit international business development organization helping to facilitate regional growth through global trade, has received nearly $682,000 to help increase medical device trade between Western New York (WNY) manufacturers and China. In that pot of money is $218,000 from the U.S. Department of Commerce.
Through a program that will be administered over a three-year time period, WTCBN and partners that work with medical device companies will enhance trade relations knowledge to place devices in one of the largest populace nations in the world. Partners include the University at Buffalo’s New York State Center of Excellence in Bioinformatics and Life Sciences, the Buffalo Niagara Medical Campus, The Buffalo Niagara Partnership, MedTech, the Jacobs Institute and the Department of Commerce, in addition to others who assist and house medical device companies.

“This three-year project will serve as a template for a greater regional export strategy,” said Chris Johnston, president of WTCBN. Johnston also stated that it will be “a great opportunity for collaboration among various groups, including the federal, state and regional government, with local organizations such as the Buffalo Niagara Medical Campus, UB and World Trade Center Buffalo Niagara, which will maximize the benefits for Western New York companies.”

The Accelerating Upstate New York’s Competitiveness and Exports in the Global Economy program will offer training and expertise to least 40 local manufacturers, teaching them how to navigate Chinese import laws, how to effectively market their products in China and the logistics of shipping goods there. They will also provide access to export loans and credit insurance. An estimated $25 million could come from Chinese contracts over a four-year period, leading to the creation of hundreds of jobs in this area.

At a roundtable discussion moderated by Congresswoman Kathy Hochul, New York’s 26th Congressional District Representative, companies had the opportunity to ask questions and receive feedback on how to identify and capitalize on new medical device markets, and to learn more about the program. Congresswoman Hochul said the program is “a critical step toward opening new markets, fostering innovation, and expanding manufacturing right here at home. Meaningful investment in Western New York’s medical device industry and work force will help add good-paying, sustainable jobs to our local economy.” The discussion served as an indicator of the collaboration and knowledge-sharing between experts and companies that is soon to come.

Congresswoman Hochul also said “It is vital that we continue to work to ensure our local businesses have the resources necessary to expand and reach new global markets.” With over $1.9 trillion in exportation of goods and services in 2011, China is currently the largest exporting country in the world. Efforts to increase the importation of medical devices made from the U.S., more so in the WNY region to China, will undeniably generate revenue increases for many local companies.

The U.S. Commerce Secretary, Rebecca Blank, stated that “The awards given by the Commerce Department’s Market Development Cooperator Program will help us continue to make progress toward achieving the President Obama’s goal of doubling exports by the end of 2014. Higher exports lead to more jobs: in 2011, jobs supported by exports increased by 1.2 million over 2009.”

The Buffalo Niagara Medical Campus, Inc.’s COO, Patrick J. Whalen stated that “the Department of Commerce grant will showcase the assets in Western New York to medical device companies around the world, and we look forward to working together to help existing companies succeed and grow.”

While WNY is home to nearly 250 medical equipment manufacturers and medical research centers, WTCBN reports that an overwhelming majority of the companies export their goods to the one country it is closest to which is Canada. Past innovations from the region include the implantable pacemaker, the Prostate-Specific Antigen (PSA) test, photodynamic therapy (used to treat malignant cancers), and multiple sclerosis therapy.

The inaugural session of the 2012-13 Life Sciences Commercialization Lecture Series will present an opportunity for local companies to learn more about the program. The session will take place on Thursday, September 27 from 4-5 p.m. at the New York State Center of Excellence in Bioinformatics and Life Sciences located at 701 Ellicott Street. For more information and to register for the event, click here.

UB CAT Awards More Than $415,000 to 16 WNY Companies Developing Life Sciences Technologies

July 18, 2012 by BNMCin Life Sciences Companies, Member Institution(s), NewsLeave a Comment

News Release

UB CAT Awards More Than $415,000 to 16 WNY Companies Developing Life Sciences Technologies

Contact

Marcene Robinson

marcener@buffalo.edu

716-645-4650

Release Date: July 18, 2012

BUFFALO, N.Y. — The University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) has awarded more than $415,000 to companies in Western New York to aid them in the development of new life sciences technologies.

The funding will support a range of projects in the 2012-13 fiscal year, from development of eye-controlled keyboards to development of a new cancer immunotherapy. Companies must work with a UB professor as principal investigator, and also get access to UB facilities and equipment.

Firms receiving an award, which typically ranges between $10,000 and $50,000, must match the funding with their own money.

The UB CAT is one of 15 centers across New York State that Empire State Development’s Division of Science, Technology and Innovation (NYSTAR) funds to support university-industry collaboration in research, education and technology transfer. The focus is on linking academic research with commercial interests to help New York State-based businesses gain a technological edge on their competition.

UB received its most recent re-designation by NYSTAR as a Center for Advanced Technology in 2007. The designation lasts 10 years, during which the UB CAT receives nearly $1 million annually from NYSTAR.

Since 2005, the UB CAT has supported over 75 projects leading to more than $140 million in non-job economic impact. The center has also helped Western New York’s life sciences sector create over 280 new jobs.

“The UB CAT provides companies with funding and resources during a critical stage in the development of new technologies,” said Marnie LaVigne, UB associate vice president for economic development. “The projects we have supported over the years have helped create jobs in New York State, facilitated long-term partnerships between UB and industry, and led to the commercialization of new and improved life sciences products and services.”

This year, 16 businesses were chosen from a group of 22 wp-contentlicants, all vying for aid in creating new technologies that benefit the fields of health and medicine.

One such company, IMMCO Diagnostics Inc., will use its $40,000 award to develop a more sensitive and specific test for Sjogren’s syndrome, an autoimmune disease in which white blood cells attack the glands that produce tears and saliva.

The syndrome is the second most common autoimmune disease, affecting some 4 million Americans. Nine out of 10 patients are women, including tennis champion Venus Williams.

Williams was first diagnosed with this disease in 2011, but suffered with Sjogren’s for a while before doctors could determine the cause.

Current tests for Sjogren’s syndrome are not sensitive enough, missing almost two-thirds of cases. However, research by Julian Ambrus Jr., MD, rheumatologist, immunologist and an associate professor in UB’s Department of Medicine, led to the discovery of a diminished protein in those with the syndrome.

IMMCO, founded in Buffalo in 1971 by several UB professors, is one of the world’s first autoimmune disease diagnostic companies. Their lab will manufacture the new testing kits, which will detect the disease in 70 to 80 percent of patients.

“Most autoimmune diseases are difficult to diagnose, simply because we really do not know the exact causes for most of them,” said Lakshmanan Suresh, assistant vice president of lab services at IMMCO. “This collaboration between IMMCO and UB will help diagnose the disease earlier so treatment can be delivered sooner.”

He adds, “The grant also helps us get this test from the bench stage to the market quicker.”

Information regarding the UB CAT and the center’s award wp-contentlication process is available online at http://www.bioinformatics.buffalo.edu/cat.php.

RPCI Launches New Applications

June 25, 2012 by BNMCin Homepage, Member Institution(s), NewsLeave a Comment

Roswell Park Cancer Institute (RPCI) launched its new digital edition of Roswellness, a consumer magazine dedicated to sharing advancements in cancer research and care. The magazine’s first digital issue, “Redefining Survivorship” is available to all iPad users. The free digital issues can be downloaded from the Apple Store. Users can go to library and click on the cover graphics to launch the interactive publication. The RPCI mobile website for smartphones will be up and running on June 25th.
“Taking advantage of new technology tools is attractive because they enable significant cost savings, along with broader reach, thus enhancing our ability to share information,” said Roswell Park President and CEO Donald L. Trump, MD. “These web- and wp-contentlication-based tools are interactive and more engaging than conventional print communications, and they give us even better ways to tell our story, share with the reader what we do and recommend to them resource links they should know about.”

RPCI is one of the first healthcare organizations to create an interactive digital publication. Roswellness has been created using the same technology major publications like Time and Sports Illustrated use to craft their digital editions.

“Going digital with the magazine allowed us to create a fuller, more dynamic user experience,” said Julie Wesolowski, Roswellness editor, who will be demonstrating the publication in the Survivorship Tent at The Ride For Roswell June 22nd–23rd at the University at Buffalo. “We incorporated lots of interactive elements into this first digital edition — an animated cover design, slide shows, video, maps and social media feeds. With all those elements at our disposal, we were able to include incredible resources for Ride For Roswell participants and volunteers.”

“Our trending over the years has shown an increase in our customers moving to our web-based wp-contentlications, and now we’re seeing more than 10,000 users a month accessing RoswellPark.org from mobile phones,” says Laurel DiBrog, Vice President of Marketing, Planning and Public Affairs, “so our goal will be to continue to enable users to get all the functionality of our main site — information and navigational tools for our patients and our other audiences, job listings and wp-contentlication forms, clinical trials — in a format that’s more convenient and easier to read from those devices.”

The PCA Group

March 25, 2012 by BNMCin Innovation CenterLeave a Comment

The PCA Group is a technology leader in the Buffalo, New York, serving small-, mid- and large-sized organizations in all industries. PCA’s family of I.T. services include outsourced I.T. support, custom wp-contentlication & software development, VoIP business phone systems, internet marketing services, and website design & development.
Website: www.thepcagroup.com

Leveraging Technology

March 25, 2012 by BNMCin Innovation CenterLeave a Comment

Leveraging Technology is a leading software consulting company serving the challenges of contemporary businesses. The combination of their deep business consulting skills and extensive technical experience can help your business achieve the results you desire.
Leveraging Technology is committed to enhancing the clients’ bottom-line business results. The company’s wp-contentroach combines deep expertise in both business processes and software solutions. Its experts thoroughly analyze and assess our clients’ specific business process, then wp-contently software solutions to make those processes more efficient, better streamlined, and ultimately more profitable.

Website: www.leveragingtechnology.com